124 related articles for article (PubMed ID: 8379679)
21. [Waldenström's macroglobulinemia effectively treated with chronic daily oral administration of low-dose etoposide].
Itoh K; Shimada T; Horibe T; Kawai N; Sakata T; Fukuda M; Murohashi I; Bessho M; Takeuchi H; Hirashima K
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2131-4. PubMed ID: 9838919
[TBL] [Abstract][Full Text] [Related]
22. CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis.
Ohata J; Matsuoka M; Yamashita T; Tojo A; Tani K; Asano S
Int J Hematol; 1999 Feb; 69(2):92-5. PubMed ID: 10071457
[TBL] [Abstract][Full Text] [Related]
23. [ATL (lymphoma type) presented with a mass formation in the heart].
Toyama T; Kubuki Y; Okamoto M; Hidaka T; Ishizaki J; Tsubouchi H
Rinsho Ketsueki; 2002 Dec; 43(12):1055-60. PubMed ID: 12607995
[TBL] [Abstract][Full Text] [Related]
24. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
[TBL] [Abstract][Full Text] [Related]
25. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
[TBL] [Abstract][Full Text] [Related]
26. [Indolent primary gastric adult T-cell leukemia/lymphoma with recurrent lesions limited to the stomach and duodenum].
Ishitsuka K; Utsunomiya A; Aosaki S; Tashiro Y; Takeshita T
Rinsho Ketsueki; 2002 Jul; 43(7):554-9. PubMed ID: 12229125
[TBL] [Abstract][Full Text] [Related]
27. [A case of refractory multiple myeloma effectively treated with long-term oral etoposide].
Tokiwa F; Utsunomiya A; Nakahara K; Shimotakahara S; Takeshita T; Makino T; Hanada S; Arima T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):533-6. PubMed ID: 8452392
[TBL] [Abstract][Full Text] [Related]
28. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
Yamamoto K; Nagata K; Morita Y; Hamaguchi H
Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
[TBL] [Abstract][Full Text] [Related]
29. [Graft-versus-ATLL effect induced by abrupt discontinuation of immunosuppression following allogeneic bone marrow transplantation].
Hara S; Yokote T; Akioka T; Oka S; Yamano T; Tsuji M; Hanafusa T
Gan To Kagaku Ryoho; 2005 Jun; 32(6):867-71. PubMed ID: 15984534
[TBL] [Abstract][Full Text] [Related]
30. [Oral administration of low-dose etoposide for maintenance chemotherapy in adult T cell leukemia patients].
Utsunomiya A; Takatsuka Y; Takeshita T; Makino T; Ishitsuka K; Shimotakahara S; Ohno N; Kuwazuru Y; Uozumi K; Saito T
Gan To Kagaku Ryoho; 1994 May; 21(6):839-44. PubMed ID: 8185342
[TBL] [Abstract][Full Text] [Related]
31. [Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
Yamamoto Y; Ishii K; Nomura S; Fukuhara S
Rinsho Ketsueki; 2004 Mar; 45(3):247-9. PubMed ID: 15103941
[TBL] [Abstract][Full Text] [Related]
32. [An intensive chemotherapy of adult T-cell leukemia/lymphoma].
Taguchi H
Rinsho Ketsueki; 1996 Aug; 37(8):654-60. PubMed ID: 8827873
[TBL] [Abstract][Full Text] [Related]
33. [Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
Fukushima T; Sawaki T; Shimoyama K; Karasawa H; Masaki Y; Kawabata H; Ogawa N; Wano Y; Hirose Y; Sugai S; Sutoh H; Itoh H; Kojima Y
Gan To Kagaku Ryoho; 2005 Feb; 32(2):251-3. PubMed ID: 15751644
[TBL] [Abstract][Full Text] [Related]
34. [Oral administration of etoposide therapy in refractory malignant lymphoma and adult T cell lymphoma].
Honda J; Osabe S; Yosida K; Nakamura E; Tanaka K; Natori H; Oizumi K; Sakamoto A; Imamura Y; Naito K
Gan To Kagaku Ryoho; 1991 Apr; 18(4):653-6. PubMed ID: 2012405
[No Abstract] [Full Text] [Related]
35. [An elderly case whose residual malignant lymphoma was completely remitted by oral etoposide treatment using unusual dosing schedule].
Soga T; Sakane Y; Fukuhara S
Gan To Kagaku Ryoho; 1997 Feb; 24(3):361-4. PubMed ID: 9051141
[TBL] [Abstract][Full Text] [Related]
36. [Adult T cell leukemia lymphoma in Chile. A clinical pathologic and molecular study of 26 patients].
Cabrera ME; Labra S; Meneses P; Matutes E; Cartier L; Ford AM; Greaves MF
Rev Med Chil; 1999 Aug; 127(8):935-44. PubMed ID: 10752254
[TBL] [Abstract][Full Text] [Related]
37. [A case of chronic adult T-cell leukemia benefited by small doses of MEPP].
Nishizaki H; Sumida M
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3291-5. PubMed ID: 3196046
[TBL] [Abstract][Full Text] [Related]
38. [Adult T-cell leukemia lymphoma with metastatic calcification].
Furukawa Y; Tanaka K; Hasuike T; Hirai M; Misu K; Ohira H; Ohta K; Yasui Y; Nakao Y; Inoue T
Rinsho Byori; 1991 Aug; 39(8):886-90. PubMed ID: 1920888
[TBL] [Abstract][Full Text] [Related]
39. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
40. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
